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Long-lived proteins are subject to spontaneous degradation
and may accumulate a range of modifications over time, in-
cluding subtle alterations such as side-chain isomerization.
Recently, tandemMS has enabled identification and character-
ization of suchpeptide isomers, including those differing only in
chirality. However, the structural and functional consequences
of these perturbations remain largely unexplored. Here, we
examined the impact of isomerization of aspartic acid or epi-
merization of serine at four sites mapping to crucial oligomeric
interfaces in human A- and B-crystallin, the most abundant
chaperone proteins in the eye lens. To characterize the effect of
isomerization on quaternary assembly, we utilized synthetic
peptide mimics, enzyme assays, molecular dynamics calcula-
tions, and native MS experiments. The oligomerization of
recombinant formsofA- andB-crystallin thatmimic isomer-
ized residues deviated from native behavior in all cases. Isomer-
ization also perturbs recognition of peptide substrates, either
enhancing or inhibiting kinase activity. Specifically, epimeriza-
tion of serine (ASer-162) dramatically weakened inter-subunit
binding. Furthermore, phosphorylation of BSer-59, known
to play an important regulatory role in oligomerization, was
severely inhibited by serine epimerization and altered by
isomerization of nearby BAsp-62. Similarly, isomerization of
BAsp-109 disrupted a vital salt bridge with BArg-120, a con-
tact that when broken has previously been shown to yield aber-
rant oligomerization and aggregation in several disease-associ-
ated variants. Our results illustrate how isomerization of amino
acid residues, which may seem to be only a minor structural
perturbation, can disrupt native structural interactions with
profound consequences for protein assembly and activity.
Long-lived proteins are important but often underappreci-
ated, with recent findings illustrating their pervasivenesswithin
critical organs and suggesting that their chemistry and biology
should not be ignored (1, 2). Longevity renders proteins suscep-
tible to degradation via nonenzymatic, spontaneous chemical
modifications, including truncation, cross-linking, oxidation,
deamidation, isomerization, and epimerization (1, 3). Aspartic
acid residues aremost prone to isomerization (4), readily form-
ing a succinimide ring following attack of the side chain by the
peptide backbone. The succinimide is susceptible to racemiza-
tion and can reopen in two ways, ultimately yielding four iso-
mers: L-Asp, D-Asp, L-isoAsp, and D-isoAsp (5). The time scale
for this process is likely dependent on many factors and will
vary for each protein, but knockout experiments in mice have
demonstrated that absence of the repair enzyme that targets
L-isoAsp leads to fatal consequences within 4–6 weeks (6, 7).
Deamidation of asparagine can also yield four isomers of
aspartic acid, but this process involves chemical substitution in
addition to isomerization. Aspartic acid isomerization is one of
the most prevalent degradation pathways of crystallin proteins
in aged human lenses and is known to increase with age. Serine
is also frequently found to undergo isomerization in long-lived
proteins; this localized chiral inversion, known as epimeriza-
tion, produces D-Ser (4, 8). Isomerization and epimerization
(illustrative examples shown in Fig. 1) are difficult to detect
because they do not lead to a change in mass and are conse-
quently invisible to mass spectrometry (MS)-based methods
typically employed during proteomic analyses (9, 10). As a
result, they are not widely studied and are frequently over-
looked, and their consequences at the molecular level are
largely unknown. Among the few previously reported exam-
ples, a study of hen egg white lysozyme with an L-isoAsp sub-
stitution at Asp-101 caused a backbone deflection of nearly 90°
relative to the native structure (11), and L-isoAsp-32 insertion
into RNase forms a protruding U-shaped loop bent by nearly
90° instead of an -helix (12). Isomerization can also affect
physical properties such as solubility and bioactivity, with
isomerization of Asp-92 in immunoglobulin 2 (IgG2) leading
to deactivation of the antigen-binding region (13).
The crystallin proteins of the eye lens, in which there is no
protein turnover, are among the longest-lived proteins in the
body (14). They are ideal targets for studying spontaneous deg-
radation pathways that occur due to aging, and experiments
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have previously revealed that isomerization compromises
water solubility and oligomerization (15–18). The most abun-
dant crystallins in humans, A and B, are important molecu-
lar chaperone (19) and regulatory proteins (20). AlthoughA is
localized almost exclusively to the eye lens (21), B is found
throughout the body (22, 23). Crystallin malfunction due to
mutation or accumulation of PTMs4 is associatedwith a variety
of diseases, including cataract, cardiomyopathies, motor neu-
ropathies, and neurodegeneration (3, 24, 25).
A and B are members of the small heat-shock protein
family (19), with structures characterized by a highly conserved
-crystallin domain (26) flanked in both proteins by less
ordered N- and C-terminal regions (Fig. 2A). Outside of the
-crystallin domain, A and B share only modest sequence
homology (21). Despite this, A and B self- and co-assemble
into large, polydisperse, and dynamic oligomers. A number of
interfaces mediate this oligomerization, which begins with
dimerization between pairs of ordered -crystallin domains.
The dimers then associate into oligomers via an interface
between a palindromic sequence in the C-terminal region of
one dimer and the -crystallin domain of another, as well as
interactions involving N-terminal regions (Fig. 2B) (27–29).
Perturbation of the dimer interface, as occurs in the well-
known R120G variant of B (30) or mutations in the terminal
regions, can lead to protein aggregation and malfunction (31).
The chaperone capacity and localization of B are also partially
regulated by phosphorylation of three serines in theN-terminal
region, with dysregulation leading to disease (32–36).
We recently reported 81 sites of isomerization in human A
and B isolated from the eye lenses of aged donors (17). Here,
we examine the structural consequences of isomerization at
four of these sites that reside in regions critical for oligomeri-
zation, and our experiments demonstrate how key structural
interactions or functionality are disrupted by isomerization.
NativeMS (37, 38) in conjunctionwith synthetic isomers, enzy-
matic assays, and molecular dynamics (MD) simulations were
used to probe the structural consequences. Our results demon-
strate that age-related isomerization of individual amino acid
residues can have significant impact on the quaternary struc-
ture and function of -crystallins, and they suggest that similar
“invisible” PTMs in other long-lived proteins may have impor-
tant influences on age-related diseases.
Results and discussion
A andB accumulate isomeric PTMs at their interfaces
The structures of the -crystallin domains of A- and
B-crystallin are very similar. Therefore, to orient where sites
of interest reside in both proteins, the-crystallin domain ofB
is used as a representative model in Fig. 2A. In the process of
oligomeric assembly, monomers first come together to form
dimers. As seen in Fig. 2A, left, the dimer interface is defined by
an anti-parallel -sheet formed by the same sequence region
from two different monomers. Hydrogen bonding along the
intermolecular -sheet and two complementary Arg-120–
Asp-109 salt bridges stabilize the interface. Another crucial
interaction occurs in a groove where the normally disordered
C-terminal tail can bind (Fig. 2A, right). This interface is one of
several that facilitates the assembly of dimers into larger oligo-
mers. The disordered N-terminal tail also forms quaternary
interactions favoring oligomerization in the general region
shown in Fig. 2A, left, although the interaction partners are
omitted for clarity. All of these regions are critical for proper
crystallin assembly and function, suggesting that structural per-
turbations within these interfaces could have undesirable
consequences.
Previous analysis identified (17) (without detailed study)
four sites of isomerization within these regions. Given the
potential structural impact, we now examine these sites in
detail. Identification of isomerization and epimerization
first requires proteolysis. Tryptic digestion of the crystallins
yields three peptides that contain the four sites of interest
(underlined): A-158AIPVSR163, which lies in the C-terminal
region; B-57APSWFDTGLSEMR69, which encompasses
residues involved in an N-terminal interface; and B-
108QDEHGFISR116, which lies in the -crystallin domain at
the dimer interface. Each of these peptides corresponds to
one of the pink regions in Fig. 2A. The degree of isomeriza-
tion or epimerization at each site was determined with RDD-
MS, as described in detail previously (17), and the results are
shown in Fig. 2, B–E and Tables S1–S4. These data were
obtained from the nucleus and cortex of a 72-year-old
human lens, although the results are similar to those from
younger donor lenses (data not shown). The complete crys-
tallin sequences, including all known isomerized and
epimerized residues, are listed for reference in Fig. S1 along
with additional details about isomer identification in Fig. S2.
RDD-MS results for A-158AIPVSR163 are shown in Fig. 2B.
The ratio of the product ions at 350.25z and 364.00 m/z varies
with elution time across the chromatographic peak for the
4 The abbreviations used are: PTM, post-translational modification; PDB, Pro-
tein Data Bank; MD, molecular dynamics; CID, collision-induced dissocia-
tion; WI, water-insoluble; WS, water-soluble; BME, -mercaptoethanol;
RDD-MS, radical-directed dissociation-mass spectrometry.
Figure1. Correspondingchemical and three-dimensional structuresof the isomersandepimers examinedherein.3D structures are shown fromabove,
with the backbone perpendicular to the plane of the page.
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water-insoluble (WI) fraction (compare the red and black rear
mass spectra in Fig. 2B). In contrast, the RDD spectra for the
water-soluble (WS) fraction do not vary as a function of reten-
tion time, as shown in the forward mass spectra of Fig. 2B. The
WS spectra both match RDD data obtained from a synthetic
L-Ser isomer. The changing product ion ratios for the WI frac-
tion are meaningful because the radical in RDD is created pho-
tolytically (39) at a single, atomically precise location in both
isomers. Subsequent collisional activation stimulatesmigration
of the radical and fragmentation of the peptide. Differences in
three-dimensional structure due to isomerization therefore
lead to differences in radical migration, which impacts the
abundance of certain fragment ions. Therefore, the varying
product ion ratios for the WI fraction in Fig. 2B reveal isomer-
ization of the peptide, even though this modification is not
readily apparent by chromatography. Further analysis with syn-
thetic standards confirms epimerization at ASer-162 and
enables quantification of the abundance of AD-Ser-162 at 8%
(see Fig. 3 for details) (40). The similarity of RDD spectra across
theWSpeak indicates absence of isomerization in that fraction.
Variations in the relative abundance between theWI/WS frac-
tions may correlate with perturbed oligomerization, as dis-
cussed in more detail below.
This approach can also be applied to more complex sys-
tems, as illustrated by the chromatograms for separation of
B-57APSWFDTGLSEMR69, from which nine different iso-
mers were identified in the WI fraction (Fig. 2C, bottom). Syn-
thetic standards of selected candidates were used to determine
that the original all-L peptide comprises only 14% of the total
abundance in the WI fraction (peak 7, which dominates the
WS fraction). The BD-Ser-59 epimer is present in 5.6%
abundance (peak 4) in the WI fraction and 1.4% in the WS
fraction (see Fig. S3 for more information). Interestingly,
when B-57APSWFDTGLSEMR69 is phosphorylated at
BSer-59, only a single isomer is detected in the WS fraction
(Fig. 2D), and a small number of isomers are detected in the
Figure 2. A, two views of the partial crystal structure of -crystallin (B, PDB 4M5S). The structure of B is used for illustration purposes because B and A
intermix freely and share high structural similarity. Blue-shaded regions indicate crucial oligomeric interfaces. Pink ribbons denote the isomer-containing
peptides, with specific isomerization sites labeled in red. The small cartoon in the middle represents the assembly, with each half-ellipse representing a
monomer, the central line indicating the dimer interface, and the peripheral lines representing bound C-terminal peptides. Extracted ion chromatograms: B,
A158AIPVSR163 from theWI (black trace) andWS (gray trace) fractions of the cortex. Insets, RDDmass spectra from the leading and trailing edge of each peak.
C, B, 57APSWFDTGLSEMR69 from the nucleus, revealing abundant isomerization in the WI fraction. D, phosphorylated 57APsWFDTGLSEMR69 detected in the
WScortex (gray trace) andWI cortex (black trace), revealing far less isomerization (where sphosphoserine). Inset,MS/MSpinpoints the siteofphosphorylation
to Ser-59. E, B, 108pQDEHGFISR116 from the cortex (where pQ pyroglutamate). The abundance of L-isoAsp is much higher in the WI than WS fraction.
Figure 3. A, selected-ion chromatogram for 4IB-AIPVSR in the WI cortex
digest of the 72-year-old lens. B, RDD spectra from the leading (peak 1a) and
trailing (peak 1b) edges of the corresponding LC peak. C, calibration curve is
then used to quantify the amount of D-Ser that co-elutes in the LC chromat-
ogram. The curve is generated by making standard solutions that contain
known amounts of both isomers and taking the difference over the sum of
the two peaks that have the largest differences in the fragmentation spectra.
For this peptide, the–29I–NH3 losses from theprecursor ion and the –H2O loss
from the precursor ion were chosen as the diagnostic peaks. The percent
D-Ser/L-Ser in the digest is then determined by averaging the RDD spectra for
the entire peak inA (indicated by the red bar). This valuemaps to the red point
in C, 92% L-Ser and 8% D-Ser.
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WI fraction. This suggests that there is a relationship
between phosphorylation and isomerization. Finally, theWS
and WI fractions of B-108QDEHGFISR116 both contain
multiple isomers of BAsp-109 (Fig. 2E), but the relative
abundance of BL-isoAsp-109 increases from 5.1 to 55.4% in
the WI portion. This dramatic difference may suggest that
isomerization of BAsp-109 influences aggregation propen-
sity. Upon detailed examination, it is clear that isomerization
and epimerization are occurring in regions known to be crit-
ical for the proper function and assembly of the -crystallins.
Furthermore, these results hint at structural consequences
(as suggested previously in relation to observations of aggre-
gation (16, 17)), but more detailed investigation is required
to reveal how these modifications exert structural influence
at the molecular level.
Epimerization of the C-terminal region compromises binding
to-crystallin domain
Ser-162 fromA is an epimerized residue located adjacent to
the highly conserved palindromic IX(I/V) motif within the
C-terminal region that binds to a groove in the -crystallin
domain (Fig. 2A). Examination of the available crystal struc-
tures (Fig. 4A) reveals that the C-terminal tail can occupy the
groove in the 83 4 direction or the inverse direction (43
8), stabilized by hydrogen bonding between the peptide back-
bones in either case (41). Although the binding to this groove
is dynamic and can occur through two different states, these
interactions are crucial for proper oligomerization, and prior
work has shown that pointmutations can influence the kinetics
and thermodynamics of assembly (42).
To quantify the effect of BSer-162 epimerization on binding
within this groove, we conducted a series of native MS ex-
periments similar to previous work examining interactions
between the -crystallin core domain and peptide portions of
the C-terminal tail (42). This native MS approach shows excel-
lent agreement with NMR-based titrations (43), with the added
benefit of being able to accommodate the heterogeneity of the
system that other methods average over. The core domains,
when analyzed alone, yield peaks corresponding to monomer
(A) and both monomer and dimer (B) (Fig. 4, B and C, lower
spectra). This suggests that the A dimer interface is slightly
weaker than that of B, although the native dimer complex can
be preserved and detected with native MS for both proteins.
Competition binding experiments between the -crystallin
domain and palindromic peptides containing either D- or L-Ser-
162 are shown in themiddle and upper mass spectra of Fig. 4, B
and C, and summarized in D. The canonical all L-amino acid
form of the peptide, ERAIPVSRE, and a D-isomer variant
made distinguishable by addition of glycine to both termini,
GERAIPVSREG (S  D-Ser), were added at a 4:1 peptide/-
crystallin domain molar ratio. The dominant adduct
observed corresponds to the binding of the canonical pep-
tide, with the D-isomer representing only a small fraction of
the binding (Fig. 4D).
To eliminate the possibility that the additional glycine resi-
dues might be responsible for the difference in binding, the
inverse experiment was conducted with the appended-glycine
L-isomer (Fig. 4, B and C, and insets, upper spectra). Binding of
the L-isomer dominates again in both systems (Fig. 4D), and the
data can be used for quantification (44, see Table S5) of the
dissociation constants: A core L-Ser 48M, B core L-Ser
115M,Acore D-Ser 650M, andB core D-Ser 1380M.
Based on these values, epimerization leads to destabilization
of G6 kJ/mol. All of these results are consistent with
D-ASer-162 significantly inhibiting proper interaction
between the C-terminal palindrome and the 4–8 groove
in the -crystallin domain.
We have previously shown that removal of the side chain
at the equivalent position in B (BT162A) leads to a weaker
interaction in the peptide–-crystallin domain system and
faster subunit-exchange of full-length B (42). The present
data suggest that epimerization of ASer-162 similarly weak-
ens binding, which would also be expected to perturb the
dynamics and chaperone activity of A. Furthermore,
because the diversity of binding modes between the C-ter-
minal tail and the -crystallin domain promotes polydisper-
sity and aids in preventing crystallization (41), disruption of
this binding may lead to increased oligomerization and
explain the high abundance of the isomerized peptide in the
WI lens fraction. Because both chaperone activity and poly-
dispersity are presumed to help maintain lens transparency
(31, 45), epimerization of ASer-162 is a likely contributor to
age-related protein aggregation within the lens.
Figure 4. Competition experiments reveal a strongpreference for L-over
D-Ser-162 binding to both A and B. A, aligned crystal structures of the
-crystallin domain (gray) with C-terminal peptide bound in two alternate
orientations. Arrows indicate orientation (N3 C) of bound peptides (green
and teal). Equivalent isomerization sites (Ser-162 in A or Thr-162 in B) are
shown in red.B,nativemass spectra ofAcore alone (bottom) andmixedwith
4:1 ERAIPVSRE and GERAIPVSREG (middle, S D-Ser). As seen in the magnifi-
cation of 6 peak, bottom spectrum, the binding of the lighter mass L-epimer
is preferred. The upper trace corresponds to the reverse experiment, i.e.
ERAIPVSRE and GERAIPVSREG. Dashed lines guide the eye to expected posi-
tions of D-epimer–bound peaks. C, equivalent experiments using the core of
Byieldsimilar results.D, relativeaveragefractionsof freeversusboundmono-
mer cores from competition experiments, using all 5, 6, and 7 charge
states for quantitation. Error bars represent 95% confidence intervals. Crystal
structures are as follows: bovine, Bt, in teal, PDB 3L1F, and zebrafish, Dr, in
green, PDB 3N3E.
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Phosphorylation is precluded by epimerization of BSer-59
and affected by isomerization of BAsp-62
Many observations suggest that BSer-59 is a structurally
important site, including solid-state NMR data showing
BSer-59 is involved in various inter-monomer contacts (46).
As illustrated in Fig. 2C, the peptide containing BSer-59 and
BAsp-62 is highly isomerized in a normal lens. In addition, the
degree of epimerization at Ser-59 increases in cataractous
lenses (8). Ser-59 is also a primary site of phosphorylation inB,
which helps regulate oligomeric size and activity (47).However,
within the lens phosphorylation is primarily observed in the
younger cortex (48).
To investigate the influence of BSer-59 epimerization and
BAsp-62 isomerization on phosphorylation, we incubated the
corresponding synthetic isomers of FLRAPSWFDTG-NH2
with the native kinase, MAPKAPK-2 (49). The extracted ion
chromatograms for both peptides reveal that the ratio of L-/D-
Ser-59 phosphorylation is 240:1 after 2 h and 350:1 after
12 h of incubation (Fig. 5,A and B), indicating that the D-Ser-59
isomer is a poor substrate for the kinase. Interestingly, exami-
nation of the phosphorylated peptide in the lens reveals only
minor isomerization (Fig. 2D), offering sharp contrast to the
abundant isomerization of the unmodified peptide. This sug-
gests that modifications elsewhere on the peptide may also
inhibit phosphorylation, or that phosphorylation prevents
isomerization, or both. Additional in vitro experiments con-
firmed that phosphorylation is inhibited by D-isoAsp-62, but
slightly enhanced by D-Asp or L-isoAsp at the same position
(Fig. 5B). In sum, the native kinase activity is affected by all three
non-native Asp isomers and essentially prevented by epimeri-
zation of Ser. These results provide a potential explanation for
previous experiments that failed to isolate phosphorylated
D-Ser from erythrocytes (50).
Ser-59 andAsp-62 have also been suggested to be involved in
an interfacial salt-bridge cluster with Arg-163 and Glu-165 of
an adjacentmonomer (51). In thismodel, all four residues are in
close proximity, with isomerization of Asp-62 or Ser-59 both
likely to perturb the dynamics of the salt bridge and disrupt the
interface (Fig. 5C). Similarly, phosphorylation of Ser-59, which
resides 2.4 Å (O–O distance) from Asp-62, is likely to disrupt
this salt bridge network and may account for the reduced oli-
gomer size observed for phosphorylationmimics of Ser-59 (52).
Disruption of this salt-bridge cluster is explored further in
experiments with recombinant proteins below.
Isomerization of BAsp-109 breaks dimer-stabilizing salt
bridge and leads to insolubility
Fig. 2E illustrates abundant isomerization of BAsp-109,
which is known to form an inter-monomer salt bridge with
BArg-120 in the APII register (41, 46, 53), the most populated
state in solution (54). Mutation at either site in the salt bridge
frequently leads tomalfunction and disease (53–56). For exam-
ple, the R120G mutant is genetically linked to desmin-related
myopathy (57), whereas mutation of BAsp-109 is associated
with myofibrillar myopathy (58) and cardiomyopathy (59). To
probe the structural consequences of BAsp-109 isomerization
on the dimer interface of B, in silicomutation and MD simu-
lations were utilized.
The results obtained from all-atom simulations extending
150 ns are illustrated in Fig. 6. The Asp-109–Arg-120 salt
bridge is stable for the L-Asp isomer, with a mean acceptor–
to–donor hydrogen bond distance under 2 Å (Fig. 6A, left).
For all other isomers, D-Asp-109, L-isoAsp-109, or D-isoAsp-
109, the salt bridge with Arg-120 is disrupted, and the aver-
age distances increase significantly (Fig. 6A, left). To deter-
mine the influence of Asp isomerization on the stability of
the dimer interface, we monitored the distances between the
final backbone hydrogen bond partners (His-111 and Arg-
123). Reasonable hydrogen bond distances are only main-
tained for the L-Asp isomer, with all other isomers producing
elongated distances (Fig. 6A, right). These results are illus-
trated by structural snapshots in Fig. 6B. For the L-Asp iso-
mer (upper left), a backbone hydrogen bond between His-
111 and Arg-123 links together the ends of 6  7 strands.
For the other three isomers, these partners have been shifted
to noninteracting distances due to disruption of the -sheet
dimer interface. It should be emphasized that these simula-
tions model only one of two identical salt bridges that stabi-
lize the dimer interface. In the situation where two modified
residues occupied both ends of the dimer interface, the
resulting destabilization would be expected to be signifi-
cantly worse. The results from these simulations offer an
explanation for the observed partitioning of each isomer
extracted from the lens in Fig. 2E. Specifically, the abun-
Figure 5.A, extracted ion chromatograms following incubation of FLRAPSWFDTG-NH2 and FLAPSWFDTG-NH2 (S D-Ser) withMAPKAPK-2 reveal that D-Ser is
not a viable phosphorylation substrate. B, relative degree of phosphorylation for Asp and Ser isomers of FLRAPSWFDTG-NH2. C, salt-bridgemodel (PDB 2YGD)
of an N-terminal oligomeric interface involving Ser-59 and Asp-62. Hydrogen bonds are shown using dashed yellow lines.
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dance of isomerized Asp-109 residues is much higher in the
WI fraction, whereas L-Asp-109 is the virtually the only iso-
mer present in the WS fraction, suggesting a single isomer-
ization event at Asp-109 is sufficient to drive insolubility.
The isomerization-induced loss of the dimer interface mim-
ics the effects of the R120G mutation, which is known to
cause protein aggregation (56) and increase the diversity of
conformational states (60).
Mimicking breakage of interfacial bonds by isomerization
leads to aberrant oligomerization
Our examination of the amino acid environment around
both Ser-59 and Asp-109 revealed that in both cases modifica-
tion at these sites would be likely to impact oligomerization.
Specifically, we noted that BSer-59 appears to be part of a net-
work of salt bridges, which is unlikely to accommodate a bulky
negative charge without significant rearrangement (Fig. 5C,
above). To test this prediction, we generated the phosphoryla-
tionmimic inwhich BSer-59wasmutated toAsp (BS59D) and
compared it to theWTwith nativeMS. Both proteins gavemass
spectra featuring a broad region of signal at highm/z, indicative
of a polydisperse ensemble of oligomers and consistent with
previous spectra of B (Fig. 7A) (61). Notably, the signal is at
slightly lower m/z values for the phosphomimic, consistent
with a shift to smaller stoichiometries. To quantify this
change, we performed collisional activation to remove
highly charged monomers from the parent oligomers, result-
ing in lower “charge-stripped” oligomers that are well
resolved and can be deconvolved into an oligomeric distri-
bution (Fig. 7, B and C) that faithfully reproduces the dis-
tribution present in solution (27, 61, 62). S59D yields a dis-
tribution centered on an 18-mer, smaller than the WT, and
with a stronger preference for oligomers with an even num-
ber of subunits (Fig. 7C). This suggests that phosphorylation
of Ser-59, which regulates activity and localization of B
(47), leads to destabilization of the larger oligomers, likely at
inter-dimer interfaces involving the N-terminal region. Sim-
ilarly, isomerization of Ser-59 or Asp-62 would also be
expected to disrupt the salt-bridge chain in Fig. 5C and
impact oligomerization in a comparable fashion. Generally,
previous results have found that phosphorylation at Ser-59
increases chaperone activity, suggesting that larger oligo-
mers serve to “store” chaperone capacity that can be released
on demand (35, 47, 63). Isomerization at Ser-59 or Asp-62
would also interfere with this regulation mechanism.
Although theS59Dmutant is aneffectivemimicofphosphor-
ylated Ser-59, direct probing of the structural impacts of
isomerization and epimerization is more problematic. It is not
possible to use site-directedmutagenesis to insert D-residues or
isoAsp into proteins, nor, given that both modifications are
spontaneous, is it feasible to induce isomerization or epimeri-
zation in a site-specific and controllable fashion. Direct inves-
tigation of the influence of isomerization at Asp-109 on oligo-
meric assembly is therefore not feasible in the absence of
whole-protein synthesis. Nevertheless, the MD results show
that the major consequence of L-Asp isomerization is disrup-
tion of the salt bridge with Arg-120. This outcome can bemim-
icked with a D109Amutant, where the acidic partner in the salt
bridge has been removed. Native MS experiments with this
mimic revealed oligomeric assemblies larger than those
observed with the WT protein and a lower preference for even
stoichiometries (Fig. 7C). Complementary results were also
obtained by light-scattering experiments that showed a signif-
icantly increased propensity for aggregation of D109A relative
to theWT (see Fig. S4). These results are consistent with trends
observed for the R120G variant, in which the same salt bridge is
disrupted (30). In both cases, the dimer interface is weakened
and oligomer size increases. This may explain why the L-isoAsp
variant is only observed in appreciable amounts in the insoluble
fraction obtained from lenses (see Fig. 2E). Overall, the results
Figure 6. A, distance distributions between Asp-109 and Arg-120 (left, red) and His-111 and Arg-123 (right, gray) fromMD simulations. Violin plots are shown
for each isomer of Asp-109; means are marked with black lines, with the kernel densities normalized to have the samemaximum heights. Lengths2.5 Å can
be considered to correspond to bond formation (neglecting consideration of the bond angles), whereas those longer represent absence of the bond (bound-
ary demarcated by dashed line). In all isomers other than L-Asp, the hydrogen-bond donor and acceptors are located too far apart for bond formation the vast
majority of the time. B, selected frames from MD simulations highlighting breakage of hydrogen bonds profiled in A and resultant interface destabilization.
Yellowdashes indicateH-bonds; short graydashes showconcomitantdistances following isomerizationofAsp-109; longgraydashesmark theantiparallel dimer
interface. His-111 and Arg-123 side chains have not been shown, for clarity.
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in Fig. 7 confirm that subtle changes that mimic isomerization
can impact oligomerization toward larger or smaller sizes even
in the context of the full-length proteins.
Conclusion
Isomerization and epimerization are prevalent PTMs in
long-lived proteins such as the crystallins found in the eye
lens. Although these modifications are difficult to detect and
cannot be probed by site-directed mutagenesis, we have
demonstrated that they can cause significant structural per-
turbation and loss-of-function. Epimerization of a single ser-
ine residue is sufficient to inhibit noncovalent recognition
needed to maintain proper interface strengths and dynam-
ics. Furthermore, epimerization of serine or isomerization of
nearby residues alters phosphorylation and any functionality
derived from it. By redirecting and altering the peptide back-
bone, aspartic acid isomerization can also inhibit kinase rec-
ognition and disrupt native salt-bridge interactions, leading
to improper oligomer assembly and size.
These observations show that what might appear to be
innocuous PTMs can disrupt protein structure. It is possible
to detect these modifications if they are present at 1% rela-
tive abundance to the unmodified canonical peptide (64).
Given that long-lived proteins are also associated with many
other diseases, including Alzheimer’s and Parkinson’s (1, 65,
66), it is likely that many of the structural issues highlighted
herein also contribute to loss-of-function in these patholo-
gies. The spontaneous nature of isomerization and epimeri-
zation dictates that repair will be unrealistic in most cases,
suggesting that the best strategy for avoiding loss-of-func-
tion due to such modifications would be increasing protein
turnover to prevent their occurrence in the first place.
Materials andmethods
Protein expression and purification
Core B (cABC, residues 68–153) was expressed in E. coli
and purified as described previously (54). A gene insert encod-
ing core A (cAAC, residues 59–153) was purchased from
Integrated DNA Technologies and inserted into a pET28a vec-
tor linearized with BamHI and XhoI (New England Biolabs)
using an In-Fusion HD cloning kit (New England Biolabs) to
generate a tobacco etch virus–cleavable His-tagged construct.
This was expressed and purified in the same manner as cABC
with addition of 5mMBME in all buffers prior to size-exclusion
chromatography, resulting in some population of BME-ad-
ducted protein visible in the spectra in Fig. 4. Core domains
were stored in 100 mMNaCl, 20 mM Tris, pH 8, at80 °C until
use. Full-length B was expressed and purified as described
previously (54). Mutations S59D and D109A were introduced
using a QuikChange site-directed mutagenesis kit (Agilent),
and mutants were expressed and purified in the same manner
as WT. Full-length proteins were stored in MS buffer (200 mM
ammonium acetate, pH 6.9) at 20 °C until use. Concentra-
tions were determined by UV absorbance at 280 nm.
NativeMS of core domains and peptides
Spectra were collected using a previously described protocol
(67) on a Synapt G1 IM-QToF mass spectrometer (Waters)
with parameters as follows: capillary 1.5 kV, sampling cone 40
V, extraction cone 3 V, backing pressure 3.1 mbar, trap gas
(argon) 3mlmin1, trap cell voltage 10V, transfer cell voltage 8
V. Ion mobility was enabled with parameters in the mobility
cell: IMS gas flow 22 ml min1, IMS wave velocity 320 m s1,
IMS wave height 5.5 V. Proteins were buffer exchanged into
200 mM ammonium acetate, pH 6.9, using a Biospin-6 col-
Figure 7. A, native MS of intact oligomeric assemblies of WT, S59D (phosphomimic), and D109A (isoAsp-mimic) B, which are not directly assignable due to
overlap of a multitude of charge states and stoichiometries. B, native MS with CID of the ions from A. Shading above shows regions where oligomers (n-mers)
have lost one (n-1) or two (n-2) subunits. Detailed view of the region highlighted in green shows that CID resolves the charge states of the oligomers. C,
reconstructed oligomeric distributions. Data were charge deconvolved and then corrected to account for stripped subunits.
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umn (Bio-Rad). All spectra were recorded at 10 M based on
concentration measurement post-buffer exchange. Samples
were introduced using gold-coated capillaries prepared in-
house. Lyophilized peptides-Ct (ERAIPVSRE) and G-Ct-G
(GERAIPVSREG) with L- or D-Ser- were resuspended in mil-
liQ H2O to a stock concentration of 1 mM and then diluted in
MS buffer andmixed with protein immediately prior to anal-
ysis to a final concentration of 40 M each for competition
experiments. For quantitation, monomeric species were
extracted in DriftScope (Waters) and intensities recorded
fromMassLynx using all resolved adduct peaks in addition to
apo for 5, 6, and 7 charge states. Data are reported as
the mean 	 S.D. for three replicates.
NativeMS of full-lengthB andmutants
Spectra were collected on a modified QExactive hybrid qua-
drupole-Orbitrap mass spectrometer (ThermoFisher Scien-
tific) optimized for transmission of high-mass complexes (68).
Protein concentration was 15 M by monomer. Capillary volt-
age was 1.4 kV in positive ion mode with source temperature
200 °C and S-lens RF 200%. UHV pressure (argon) was between
1.4
 109 and 1.7
 109 mbar. In-source trapping fragmen-
tation voltage ranged from150 to180 V. Ion transfer optics
were as follows: injection flatapole 10V, inter-flatapole lens 8V,
bent flatapole 6 V, transfer multipole 4 V, C-trap entrance lens
3 V. Nitrogen was used in the HCD cell and HCD energy was 0
V for intact spectra and tuned for optimal dissociation of each
protein for CID spectra, ranging from 200 to 230 V. Resolution
was kept at 17,500 atm/z 200 for a transient timeof 64ms and
the noise threshold was set to 3. For CID spectra, groupings of
30 microscans were combined to improve signal quality. Data
were visualized using Xcalibur (ThermoFisher Scientific) and
calibrated manually according to expected peak positions for
WT B-crystallin. Calibrated CID data were processed using
UniDec software, which allowed for stoichiometric assignment
and post-hoc correction for dissociated subunits (62).
Molecularmodeling
To study the effect of Asp-109 epimerization, we extracted
structures from PDB 2WJ7, which features the B-crystallin
core dimer in the A II register (thus enabling the formation of
the Asp-109–Arg-120 salt bridge). Three models featuring
D-Asp, D-isoAsp, and L-isoAsp at position 109 in one of the two
monomers, respectively, were produced by modifying PDB
2WJ7 in Schrödinger Maestro. Simulation parameters for
nonstandard amino acids were produced with Antechamber
(69, 70). All atom types were assigned according to available
ff14SB parameters. Calculations were performed using the
Amber ff14SB force field (71) on the NAMDmolecular dynam-
ics engine (72). Structures were first solvated in a box of TIP3P
water, their box charge neutralized by addition ofNa ions, and
the resulting systems energy-minimized with 2000 conjugate
gradient steps. We then performed 0.5-ns steps in the NPT
ensemble, with all protein -carbons constrained by a har-
monic potential. Langevin dynamics were used to impose a
temperature of 300 K, using a damping of 1/ps. A constant
pressure of 1 atm was imposed via a Langevin piston having a
period of 200 fs and a decay of 50 fs. The system was then
further equilibrated in the NVT ensemble for 1 ns, after which
200-ns production runs in the NPT ensemble were performed.
In all simulation steps, Particle Mesh Ewald was used to treat
long-range electrostatic interactions, with a cutoff distance of
12 Å for van der Waals interactions, and a 2-fs time step was
implemented by restraining every covalent bond with SHAKE.
His-111–Arg-123 and Asp-109–Arg-120 distances were
measured every 100 ps. For the latter, we report the shortest
distance between each of the hydrogens of Arg-120 guani-
dinium, and oxygens of Asp-109 carboxylate.
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